|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 50, 2389-2397, December 2009 AMPK inhibitor Compound C stimulates ceramide production and promotes Bax redistribution and apoptosis in MCF7 breast carcinoma cells
* Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC 29425
1 To whom correspondence should be addressed. e-mail: hsuy{at}musc.edu Compound C is commonly used as an inhibitor of AMP-activated protein kinase (AMPK), which serves as a key energy sensor in cells. In this study, we found that Compound C treatment of MCF7 cells led to Bax redistribution from the cytoplasm to mitochondria and cell death. However, this effect does not involve AMPK. In addition, we found that treatment with this compound leads to an enhanced ceramide production. Analyses by quantitative PCR and ceramide synthase activity assay suggest that ceramide synthase 5 (LASS/CerS 5) is involved in Compound C-induced ceramide upregulation. Downregulation of LASS/CerS 5 was found to attenuate Compound C-mediated ceramide production, Bax redistribution, and cell death.
Supplementary key words AMP-activated protein kinase signaling pathway sphingolipid cell death Abbreviations: ACC, acetyl CoA carboxylase; AICAR, aminoimidazole-4-carboxamide riboside; AMPK, AMP-activated protein kinase; GFP, green fluorescent protein; LASS/CerS, longevity assurance homologue/ceramide synthase; MAPK, mitogen-activated protein kinase; qPCR, quantitative polymerase chain reaction; siRNA, small interfering RNA; t-BHQ, tert-butylhydroxyquinone
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||